par De Caluwé, Alex ;Buisseret, Laurence ;Poortmans, Philip;Van Gestel, Dirk ;Salgado, Roberto;Sotiriou, Christos ;Larsimont, Denis ;Paesmans, Marianne ;Ruscas-Craciun, Ligia Ioana ;Stylianos, Drisis;Vandekerckhove, Christophe;Reyal, Fabien;Isabelle, Veys;Eiger, Daniel;Piccart, Martine;Romano, Emanuela;Ignatiadis, Michail
Référence BMC cancer, 21, 1, page (899)
Publication Publié, 2021-08-01
Référence BMC cancer, 21, 1, page (899)
Publication Publié, 2021-08-01
Article révisé par les pairs
Titre: |
|
Auteur: | De Caluwé, Alex; Buisseret, Laurence; Poortmans, Philip; Van Gestel, Dirk; Salgado, Roberto; Sotiriou, Christos; Larsimont, Denis; Paesmans, Marianne; Ruscas-Craciun, Ligia Ioana; Stylianos, Drisis; Vandekerckhove, Christophe; Reyal, Fabien; Isabelle, Veys; Eiger, Daniel; Piccart, Martine; Romano, Emanuela; Ignatiadis, Michail |
Informations sur la publication: | BMC cancer, 21, 1, page (899) |
Statut de publication: | Publié, 2021-08-01 |
Sujet CREF: | Cancérologie |
Sciences bio-médicales et agricoles | |
Médecine pathologie humaine | |
Mots-clés: | Anti-CD73 |
Anti-PD-L1 | |
Early luminal B breast cancer | |
Neo-adjuvant chemotherapy | |
Priming | |
Stereotactic body radiation therapy | |
MeSH keywords: | Adenosine -- metabolism |
Breast Neoplasms -- etiology -- metabolism -- radiotherapy | |
Chemoradiotherapy -- methods | |
Clinical Protocols | |
Combined Modality Therapy | |
Female | |
Humans | |
Metabolic Networks and Pathways -- drug effects -- radiation effects | |
Neoplasm Staging | |
Research Design | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:1471-2407 |
info:doi/10.1186/s12885-021-08601-1 | |
info:pii/10.1186/s12885-021-08601-1 | |
info:scp/85112650231 | |
info:pmid/34362344 | |
PMC8343924 |